Form 4: Taysha Gene Therapies CEO Sells Shares for Tax Obligations

Taysha Gene Therapies CEO Sean P. Nolan sold 178,101 shares of common stock to cover tax liabilities from restricted stock unit vesting.

Summary

• Sean P. Nolan, Chief Executive Officer and Director of Taysha Gene Therapies, Inc. (TSHA), reported the sale of common stock.
• A total of 178,101 shares were sold across two transactions on January 23, 2026, and January 26, 2026.
• The sales were executed pursuant to a mandatory sell-to-cover arrangement to satisfy income tax liabilities incurred upon the vesting of restricted stock unit awards.
• On January 23, 2026, 136,789 shares were sold at a weighted average price of $4.75 per share, with prices ranging from $4.635 to $4.99.
• On January 26, 2026, 41,312 shares were sold at a weighted average price of $4.61 per share, with prices ranging from $4.505 to $4.715.
• Following these transactions, Mr. Nolan directly beneficially owns 2,908,257 shares of common stock.
• Additionally, Mr. Nolan indirectly beneficially owns 1,535,545 shares through Nolan Capital, LLC, where he serves as President with shared voting and investment power.

Sentiment

Score: 5

Explanation: The transaction is a routine, mandatory sell-to-cover for tax obligations related to RSU vesting, not indicative of management's view on the company's future prospects or a change in company fundamentals.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, pre-planned insider transaction for tax purposes, not signaling a change in company fundamentals or management confidence.

Key Dates

Recommendation

The insider sale is a mandatory sell-to-cover transaction for tax liabilities incurred upon restricted stock unit vesting, which is a routine event and not indicative of a change in the company's fundamental outlook or management's confidence. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Taysha Gene Therapies, TSHA, Sean Nolan, Insider Transaction, Form 4, Stock Sale, CEO, Restricted Stock Units, Tax Obligations